Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vildagliptin plus intensive insulin versus intensive insulin alone in type 1 diabetes
ChiCTR-IPR-15005986Phase 4Recruiting
- Sponsor
- Shenzhen People's Hospital
- Start
- Nov 2011
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of vildagliptin and human insulin in diabetes mellitus type 1 (T1D) (2 arms), sponsored by Shenzhen People's Hospital. Primary endpoint: Daily acute glucose fluctuations. Started Nov 2011; status: recruiting.
02
Drugs
vildagliptinhuman insulin
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on ChiCTR-IPR-15005986.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-15005986.